Page last updated: 2024-11-04

sulfamethoxazole and Hodgkin Disease

sulfamethoxazole has been researched along with Hodgkin Disease in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, AR1
Jackson, JM1
Scopa, J1
Lane, GK1
Wilson, R1

Other Studies

1 other study available for sulfamethoxazole and Hodgkin Disease

ArticleYear
Nocardiosis: diagnosis and management, with a report of three cases.
    The Medical journal of Australia, 1971, Mar-27, Volume: 1, Issue:13

    Topics: Adult; Cephaloridine; Folic Acid Antagonists; Hodgkin Disease; Humans; Lung Diseases; Male; Middle A

1971